bayer-admits-thromboembolism-effects-and-vascular-problems-with-yasmin

YASMIN SUPPLEMENTAL NEW DRUG APPLICATION PROVIDES FOR NEW INFORMATION OF  THROMBOEMBOLISM AND VASCULAR PROBLEMS.

Bayer FDA Letter

send us a message